Landscape Capital Management, L.L.C. Adaptive Biotechnologies Corp Transaction History

Landscape Capital Management, L.L.C.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$6.5 - $12.67 $590,037 - $1.15 Million	-90,775 Reduced 33.75%	178,150 $1.27 Million
Q2 2022 Aug 05, 2022	BUY	$6.4 - $14.73 $592,531 - $1.36 Million	92,583 Added 52.5%	268,925 $2.18 Million
Q1 2022 May 11, 2022	BUY	$10.12 - $28.9 $1.13 Million - $3.22 Million	111,443 Added 171.72%	176,342 $2.45 Million
Q4 2021 Feb 01, 2022	BUY	$25.17 - $36.85 $1.63 Million - $2.39 Million	64,899 New	64,899 $1.82 Million
Q1 2021 May 11, 2021	SELL	$37.26 - $67.74 $656,632 - $1.19 Million	-17,623 Closed	0 $0
Q4 2020 Feb 09, 2021	SELL	$45.01 - $65.47 $271,995 - $395,635	-6,043 Reduced 25.53%	17,623 $1.04 Million
Q3 2020 Nov 10, 2020	BUY	$35.79 - $48.81 $847,006 - $1.16 Million	23,666 New	23,666 $1.15 Million
Q3 2019 Nov 12, 2019	SELL	$30.31 - $53.51 $198,318 - $350,115	-6,543 Closed	0 $0
Q2 2019 Aug 08, 2019	BUY	$40.3 - $48.3 $263,682 - $316,026	6,543 New	6,543 $316,000

202

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $849M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.